MIRA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	10	16	-	-
Enterprise Value	7	11	0	-3
PE Ratio	-	-1.29	-	-
PB Ratio	3.23	3.55	-	-
P/FCF Ratio	-3.61	-3.42	-	-
P/OCF Ratio	-3.61	-3.42	-	-
EV/EBITDA Ratio	-1.42	-1.28	-0.02	1.17
EV/EBIT Ratio	-1.42	-1.28	-0.02	1.17
EV/FCF Ratio	-2.83	-2.41	-0.03	1.83
Debt / Equity Ratio	0.00	0.00	-0.82	0.13
Debt / EBITDA Ratio	0.00	0.00	-0.07	-0.14
Debt / FCF Ratio	0.00	0.00	-0.09	-0.21
Quick Ratio	5.56	8.39	0.26	2.57
Current Ratio	5.70	8.71	0.36	2.66
Interest Coverage	-2.63	-2.47	-687.60	-88.30
Return on Equity (ROE)	-293.50%	-402.90%	-847.80%	-
Return on Assets (ROA)	-229.00%	-263.70%	-335.00%	-
Return on Capital (ROIC)	-283.56%	-194.69%	6712.26%	-84.25%
Earnings Yield	-121.39%	-77.21%	-	-
FCF Yield	-44.26%	-29.20%	-	-
Buyback Yield / Dilution	-11.03%	-5.69%	-	-
Total Shareholder Return	-11.03%	-5.69%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).